Major factors contributing to growth of blood culture test market include growing number of sepsis cases and high cost of treatment, increase in prevalence of infectious diseases, rapidly rising aging population, increase in product approvals and launches, increase in demand for rapid diagnostic techniques, and high incidence of bloodstream infections.
- Agency -.
Complete report on Blood Culture Tests Market spread across 249 Pages, Profiling 11 Companies and Supported with 300 Tables and 50 Figures is now available at www.rnrmarketresearch.com/blood-cu…arket-report.html
The global blood culture tests market is projected to reach USD 4,768.9 million by 2021 from USD 3,252.6 million in 2016, at a CAGR of 8.0%. North America dominates the blood culture tests market in 2016, followed by Europe.
Asia is projected to grow at the highest CAGR during the forecast period, owing to high incidence of sepsis and government initiatives to increase awareness on the disease.
Stakeholders of this Research Report are as follows
- Molecular Diagnostic Companies
- Manufacturers of Clinical Microbiology Instruments and Consumables
- Venture Capitalists
- Research and Consulting Firms
- Clinical Diagnostic Laboratories
The study suggests that Abbott’s PCR/ESI-MS can detect bacteria, viruses, or fungi in a short span of time when the blood culture tests market are negative.
- Agency -.
In addition, growth of blood culture tests market in North America driven by technological advancements and increase in demand for rapid diagnostic techniques. Various market players are focusing on new product launches to expand their product portfolios and cater to their wide customer base.
Blood Culture Tests Market, By Technology
2 Culture-Based Technology
3 Molecular Technologies
5 PCR (Polymerase Chain Reaction)
6 PNA-FiSH (Peptide Nucleic Acid – Fluroscent in Situ Hybridization)
7 Proteomics Technology
Key players in blood culture tests market include Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (U.S.), Cepheid, Inc. (U.S.), Nanosphere, Inc.
(U.S.), Roche Diagnostics (Switzerland), Beckman Coulter (U.S.), Bruker Corporation (U.S.), IRIDICA (U.S.), and T2 Biosystems (U.S.).
Increasing demand for effective diagnostic techniques, rising awareness about early disease diagnosis, increasing adoption of advanced technologies, rapid rise in geriatric population, and growing regulatory approvals & availability of blood culture test products in this region.
Global blood culture tests market is dominated by North America, followed by Europe. However, market in Asia is expected to register the highest growth rate.
Factors such as high incidence of sepsis and government initiatives to increase awareness on disease, increasing demand for effective diagnostic techniques, rising awareness about early disease diagnosis, increasing adoption of advanced technologies, rapid rise in geriatric population, and growing regulatory approvals & availability of blood culture test products in this region are contributing to high growth rate of this market segment.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: